Topic: United States
Auto-immune disorders are far morecommon that many people think, and most people probably don?t even know how youget an immune disease. As of 2001, 9% of U.S. children under18 years old had asthma, with that number growing yearly.3. Type 1 diabetes is ...
Psoriasis is a fairly common skin condition and is estimated to affect approximately 1%-3% of the US population. Also, psoriasis is due to an immune deficiency.The doctor prescribed a cream called Dovonex. When Taclonex wouldn't take the psoriasis away, I then trusted ...
Multiple sclerosis is a chronic degenerative disease of the nervous system, the cause of which is unknown. It is more common among whites than among blacks and seems to be more frequent in Europe, particularly in the Scandinavian countries, than in the ...
I have had problems with Psoriasis my whole adult life, so I try hard to make sure my skin looks healthy instead of dry or flaky and sore. Sometimes that is easier said than done though ,especially if like me and most ...
NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with a commonly used medicine in a pivotal late-stage clinical trial, the company said on Monday.In a 52-week ...
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth ...
LONDON (Reuters) - An experimental new antibody drug from Novartis has proved safe and effective in treating three diseases involving inflammation -- scaly skin, arthritis and a sore eye condition, data showed on Wednesday.Novartis researchers said the early-stage trials suggested the drug, ...
Company's Extensive Late-Stage Portfolio Could Address Unmet Patient Needs and Redefine Success in the Treatment of Multiple Sclerosis --. Data being presented will include Biogen Idec's currently marketed products, TYSABRI (natalizumab) and AVONEX (interferon beta-1a), as well as four late-stage programs: prolonged-release ...
[UPDATED 09/24/2010] Octapharma USA and FDA notified healthcare professionals that, effective immediately, Octapharma is initiating a voluntary market withdrawal of ALL lots of Octagam currently in the US market. Octapharma has determined, through consultation with the public health authorities at FDA, that ...
Gilenya has become the first oral multiple sclerosis pill capable of slowing the disease's progression and reducing relapses to win approval from the U.S. Food and Drug Administration. Many people suffering with MS in the United States are likely to take an ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
